Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

Eli Lilly Stock Tumbles Following Overturn of Prozac Patent Protection

OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry News Eli Lilly and Company stock tumbled 31% from just over $107 to $75 per share following a decision by the Court of Appeals for the Federal Circuit in Washington, District of Columbia, on August 9, 2000, regarding Lilly's patent for Prozac. The court reversed a decision in the case of Eli Lilly and Company v. Barr Laboratories, et al that had given Lilly's antidepressant drug Prozac patent protection through December 2003, raising the likelihood for generic competition as early as February 2001. On March 8, 2000 . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Eli Lilly Stock Tumbles Following Overturn of Prozac Patent Protection

OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry News Eli Lilly and Company stock tumbled 31% from just over $107 to $75 per share following a decision by the Court of Appeals for the Federal Circuit in Washington, District of Columbia, on August 9, 2000, regarding Lilly's patent for Prozac. The court reversed a decision in the case of Eli Lilly and Company v. Barr Laboratories, et al that had given Lilly's antidepressant drug Prozac patent protection through December 2003, raising the likelihood for generic competition as early as February 2001. On March 8, 2000 . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.